3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid

C18H24ClN7O4 — CID 71651163

IUPAC3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid
SMILESCCn1c(-c2nonc2N)nc2c(Cl)ncc(OCCCN(C(=O)O)C(C)(C)C)c21
InChIInChI=1S/C18H24ClN7O4/c1-5-25-13-10(29-8-6-7-26(17(27)28)18(2,3)4)9-21-14(19)11(13)22-16(25)12-15(20)24-30-23-12/h9H,5-8H2,1-4H3,(H2,20,24)(H,27,28)
InChIKeyIEBYLEIBVZRXFO-UHFFFAOYSA-N
MW437.89 g/mol
LogP3.28
Rot. Bonds7

About 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid

3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid (PubChem CID 71651163) has the molecular formula C18H24ClN7O4 and a molecular weight of 437.89 g/mol. Its IUPAC name is 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid.

Molecular Properties

Compound Name3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid
PubChem CID71651163
Molecular FormulaC18H24ClN7O4
Molecular Weight437.89 g/mol
Exact Mass437.16
IUPAC Name3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid
SMILESCCn1c(-c2nonc2N)nc2c(Cl)ncc(OCCCN(C(=O)O)C(C)(C)C)c21
InChIInChI=1S/C18H24ClN7O4/c1-5-25-13-10(29-8-6-7-26(17(27)28)18(2,3)4)9-21-14(19)11(13)22-16(25)12-15(20)24-30-23-12/h9H,5-8H2,1-4H3,(H2,20,24)(H,27,28)
InChIKeyIEBYLEIBVZRXFO-UHFFFAOYSA-N
XLogP3.28
TPSA145.42 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500437.89
LogP ≤ 53.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid?
The IUPAC name of 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid (CID 71651163) is 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid.
What is the SMILES notation for 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid?
The canonical SMILES for 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid is CCn1c(-c2nonc2N)nc2c(Cl)ncc(OCCCN(C(=O)O)C(C)(C)C)c21.
What is the InChIKey of 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid?
The InChIKey is IEBYLEIBVZRXFO-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H24ClN7O4/c1-5-25-13-10(29-8-6-7-26(17(27)28)18(2,3)4)9-21-14(19)11(13)22-16(25)12-15(20)24-30-23-12/h9H,5-8H2,1-4H3,(H2,20,24)(H,27,28).
What are the key properties of 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid?
3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid has a molecular weight of 437.89 g/mol, XLogP of 3.28, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-4-chloro-1-ethylimidazo[4,5-c]pyridin-7-yl]oxypropyl-tert-butylcarbamic acid is sourced from PubChem (CID 71651163), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).